Boston Scientific Corporation
| Plan name | Boston Scientific Corporation |
| Location | Marlborough, Mass. |
| Asset size ($MM) | $5.5 B |
| Participants | 29,900 |
| Industry | Medical devices |
| Participation rate | 95% |
| Average deferral rate | 8% |
| # of funds offered | 15 |
| Investment review | |
| True-up match | |
| Match vesting period | Immediately upon enrollment |
| Eligibility | Immediately upon hire |
| Default deferral rate | 2% |
| Default investment | Target-date Fund (all types) |
| Automatic escalation | Yes - participants are defaulted into auto escalation at time of enrollment unless they opt out; all other participants can opt in at any time |
| Systematic withdrawals | |
| Fee equalization | No, and we have no plans to research this in the short-term |
| Match Rate | 100% of first 6% of salary |
| % receiving full match | More than average (more than 50% but less than 75%) |
| Maximum employer contribution | 6% |
| Financial Education | |
Saving/Budgeting | |
Investing strategies | |
College saving | |
Credit/Debt management | |
Tax/Estate planning | |
Retiree health costs/savings options |
| Recordkeeper | Vanguard |
Get the latest news every weekday